
    
      RECITE: A phase 3 Randomized Placebo-controlled Double-blind Study of Romiplostim for the
      Treatment of Chemotherapy-induced Thrombocytopenia in Patients Receiving Oxaliplatin-based
      Chemotherapy for Treatment of Gastrointestinal, Pancreatic, or Colorectal Cancer
    
  